These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32748547)

  • 1. Association between serum NPTX2 and cognitive function in patients with vascular dementia.
    Shao K; Shan S; Ru W; Ma C
    Brain Behav; 2020 Oct; 10(10):e01779. PubMed ID: 32748547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Levels of Serum IL-34 Associated with Cognitive Impairment in Vascular Dementia.
    Wang Y; Lu W; Ning W; Chen Y; Li L
    Biomed Res Int; 2021; 2021():6793860. PubMed ID: 34095310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of serum Kallikrein-8 with cognitive function in vascular dementia.
    Li J; Li SL; Song YH; Li ZP; Wang N; Zhang GH; Zhu CL
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1997-2002. PubMed ID: 33660811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Serum FAM19A5 with Cognitive Impairment in Vascular Dementia.
    Li J; Li S; Song Y; Zhou W; Zhu X; Xu S; Ma Y; Zhu C
    Dis Markers; 2020; 2020():8895900. PubMed ID: 32831973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia.
    Ma W; Zhang J; Xu J; Feng D; Wang X; Zhang F
    Dis Markers; 2020; 2020():6612871. PubMed ID: 33204362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Serum NCAM Levels Associated with Cognitive Impairment in Vascular Dementia.
    Zhao J; Lu W; Li J; Liu L; Zhao X
    Dis Markers; 2021; 2021():2792884. PubMed ID: 34504627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Levels of Serum Neuregulin 1 Associated with Cognitive Impairment in Vascular Dementia.
    Wang X; Zhang F; Ma W; Feng D; Zhang J; Xu J
    Biomed Res Int; 2020; 2020():6683747. PubMed ID: 33274218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
    Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
    Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of vascular dementia in Thai stroke patients.
    Dharmasaroja PA; Limwongse C; Charernboon T
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104878. PubMed ID: 32417242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
    Massa F; Martinuzzo C; Gómez de San José N; Pelagotti V; Kreshpa W; Abu-Rumeileh S; Barba L; Mattioli P; Orso B; Brugnolo A; Girtler N; Vigo T; Arnaldi D; Serrati C; Uccelli A; Morbelli S; Chincarini A; Otto M; Pardini M
    J Neurol; 2024 Apr; 271(4):1999-2009. PubMed ID: 38157030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of blood-brain barrier-related blood-borne factors for Alzheimer's disease vs. vascular dementia diagnosis: A pilot study.
    Gong M; Jia J
    Front Neurosci; 2022; 16():949129. PubMed ID: 36003963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired attention function based on the Montréal Cognitive Assessment in vascular dementia patients with frontal hypoperfusion: The Osaki-Tajiri project.
    Akanuma K; Meguro K; Kato Y; Takahashi Y; Nakamura K; Yamaguchi S
    J Clin Neurosci; 2016 Jun; 28():128-32. PubMed ID: 26778514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vascular stiffness in vascular dementia, Alzheimer dementia and cognitive impairment.
    Rabkin SW; Jarvie G
    Blood Press; 2011 Oct; 20(5):274-83. PubMed ID: 21623679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neuronal pentraxin 2 is related to cognitive dysfunction and electroencephalogram slow wave/fast wave frequency ratio in epilepsy.
    Huang XF; Xu MX; Chen YF; Lin YQ; Lin YX; Wang F
    World J Psychiatry; 2023 Oct; 13(10):714-723. PubMed ID: 38058685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between Serum Amyloid A Level and Cognitive Dysfunction in Patients with Vascular Dementia: Preliminary Findings.
    Xu M; He XY; Huang P
    Biomed Res Int; 2021; 2021():6676144. PubMed ID: 33644229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of vascular cognitive impairment and dementia.
    Erkinjuntti T
    J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort.
    Forti P; Olivelli V; Rietti E; Maltoni B; Pirazzoli G; Gatti R; Gioia MG; Ravaglia G
    Gerontology; 2012; 58(1):41-9. PubMed ID: 21430364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia.
    Fuh JL; Wang SJ; Cummings JL
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1337-41. PubMed ID: 16170072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.